A fine of 18 million riyals against the Saudi German Healthcare Administration
In a decisive move reflecting the commitment of Saudi Arabian regulatory authorities to protecting investors, the Capital Market Authority a final ruling by the Appeals Committee for Securities Disputes. This ruling found 11 members of the board of directors and the audit committee of Middle East Healthcare Company, commercially known as Saudi German Healthcare,.
Details of violations and manipulation of financial statements
These convictions came as a result of violating the Capital Market Law and its implementing regulations, as the convicted individuals were found to have manipulated the company's financial statements during the period between 2018 and 2021. The Authority explained in its official statement that the violations were mainly focused on inflating the company's revenues, which led to creating a misleading and incorrect impression of its true book value.
This was achieved by recognizing undue revenues amounting to approximately SAR 358 million. Interestingly, this manipulation occurred despite the Board of Directors and the Audit Committee being aware of the limited possibility of collecting these amounts. This resulted in the inclusion of inaccurate information in the annual financial statements ending December 31, 2018, and subsequently in the interim financial statements ending September 30, 2021. This transgression directly impacted the valuation of the company's assets and misrepresented its financial position to shareholders.
Penalties imposed on convicts
Based on the scale of the violations, the Appeals Committee imposed hefty fines totaling approximately 18 million Saudi Riyals. The penalties were not limited to financial fines; the decision also included deterrent administrative sanctions, such as barring several of the convicted individuals from working for any entity under the supervision of the Capital Market Authority for a full year, while others were barred from the same work for six months.
General context and importance of the decision in the Saudi market
Company is Saudi German Healthcare one of the largest healthcare providers in Saudi Arabia and the Middle East region, and its listing on the Saudi Stock Exchange (Tadawul) makes its governance crucial. Historically, the Capital Market Authority was established to ensure transparency and fairness in the market and to protect investors from unfair, fraudulent, or deceptive practices.
This decision carries significant local, regional, and international implications. Locally, this stringent measure reinforces the confidence of individual and institutional investors in the integrity of the Saudi financial market and underscores the vigilance of regulatory bodies in addressing any violations. Regionally and internationally, such decisive actions send a reassuring message to foreign investors that the Saudi market offers a safe and transparent investment environment, aligning with the goals of Saudi Vision 2030, which aims to attract foreign direct investment and develop the financial sector.
Ongoing coordination with judicial authorities
The Capital Market Authority (CMA) affirmed that this definitive decision was not made arbitrarily, but rather as a result of continuous and effective coordination with relevant authorities. The decision was issued in light of the public prosecution case filed by the Public Prosecution, which was referred by the CMA in March 2024. In closing, the CMA emphasized its ongoing commitment to monitoring any violations and taking all necessary legal measures against perpetrators, with the aim of enhancing integrity and transparency in the Saudi financial market and protecting investors' assets.
